chr11-123976850-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004474.2(OR10S1):c.815C>A(p.Ala272Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,614,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004474.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR10S1 | NM_001004474.2 | c.815C>A | p.Ala272Glu | missense_variant | 1/1 | ENST00000641123.1 | NP_001004474.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR10S1 | ENST00000641123.1 | c.815C>A | p.Ala272Glu | missense_variant | 1/1 | NM_001004474.2 | ENSP00000493143 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251292Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135826
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461864Hom.: 0 Cov.: 36 AF XY: 0.0000124 AC XY: 9AN XY: 727232
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2024 | The c.842C>A (p.A281E) alteration is located in exon 1 (coding exon 1) of the OR10S1 gene. This alteration results from a C to A substitution at nucleotide position 842, causing the alanine (A) at amino acid position 281 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at